Potential diagnostic role of serum asprosin in Graves’ disease with subgroup analysis of subclinical hyperthyroidism: A Case–Control Study
References
- Salman AG, Mahdi IA-J, Mukhlef AK, Abd alsattar Mohammad R, Zaghir MSH, Muatez Wadaa'a N. Physiological aspects of thyroid disorders: Anatomy, hormones, diagnosis and management. Current Clinical and Medical Education. 2024;2(05):17-32.
- Phagoora J, Bakilwal S, Hamzehpour A, Kabariti M, Munarov J, Cho HY, et al. Graves Disease-A Comprehensive Review. Physician's Journal of Medicine. 2024;3(1).
- Antonelli A, Ferrari SM, Ragusa F, Elia G, Paparo SR, Ruffilli I, et al. Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses. Best practice & research Clinical endocrinology & metabolism. 2020;34(1):101387.
- Tsai K, Leung AM. Subclinical hyperthyroidism: a review of the clinical literature. Endocrine Practice. 2021;27(3):254-60.
- Zinchuk V, Al-Jebur J. Oxygen-Dependent Aspects of Asprosin Action. Journal of Evolutionary Biochemistry and Physiology. 2024;60(2):818-28.
- Kerslake R. Investigation of the role of asprosin and downstream glycolytic molecules in ovarian cancer: Brunel University London; 2023.
- Mazur-Bialy AI. Asprosin—a fasting-induced, glucogenic, and orexigenic adipokine as a new promising player. Will it be a new factor in the treatment of obesity, diabetes, or infertility? A review of the literature. Nutrients. 2021;13(2):620.
- Summers KM. Genetic models of fibrillinopathies. Genetics. 2024;226(1):iyad189.
- Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev. 2014;94(2):355-82.
- Miao Y, Qin H, Zhong Y, Huang K, Rao C. Novel adipokine asprosin modulates browning and adipogenesis in white adipose tissue. Journal of Endocrinology. 2021;249(2):83-93.
- Faul F, Erdfelder E, Buchner A, Lang A-G. Statistical power analyses using G* Power 3.1: Tests for correlation and regression analyses. Behavior research methods. 2009;41(4):1149-60.
- Cohen J. Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates; 1988.
- Vitale L, Massarini S, Ferrulli A. Study of the Basal Metabolic Rate in Thyroid Dysfunctions and Diabetes. Thyroid, Diabetes and Osteoporosis: The Bermuda Triangle: Springer; 2025. p. 85-107.
- Steinhoff KG, Krause K, Linder N, Rullmann M, Volke L, Gebhardt C, et al. Effects of hyperthyroidism on adipose tissue activity and distribution in adults. Thyroid. 2021;31(3):519-27.
- Zhang Y, Yang P, Zhang X, Liu S, Lou K. Asprosin: its function as a novel endocrine factor in metabolic-related diseases. Journal of Endocrinological Investigation. 2024;47(8):1839-50.
- Krishnamurthy H, Suresh C, Siriwardhane T, Krishna K, Song Q, Jayaraman V, et al. Association between thyroid dysfunction and insulin resistance: a retrospective cohort study. BMJ open. 2025;15(1):e076397.
Language: English
Page range: 113 - 118
Submitted on: Mar 14, 2026
Accepted on: May 13, 2026
Published on: Jul 3, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2026 Sajjad Kadhim Ashour, Mohammed Imran Hamzah, Mahmood Shakir Khudhair, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.